ResMed Inc. — First Quarter Fiscal Year 2027 Earnings Summary

ResMed reported first-quarter fiscal 2027 revenue of $1.415 billion, representing a 6% increase year-over-year and a 7% rise on a core constant currency basis. The company achieved GAAP diluted earnings per share of $2.92, a 23% increase from the prior year, while non-GAAP diluted earnings per share rose 14% to $2.91. ResMed returned over $1 billion to shareholders through dividends and share repurchases, supported by strong free cash flow of $374 million and proceeds from the divestiture of its MatrixCare business. The company also closed the MatrixCare sale, launched the AirTouch F40 CPAP mask, and announced a quarterly dividend of $0.66 per share.